MedCann Industries, Inc., Corporate Update; ANNOUNCES COMPANY UPDATE FOR 2022.

(Spin Digit Editorial):- Great Neck, New York Jun 21, 2022 (Issuewire.com) – MedCann Industries, Inc. Growing Dreams: (OTC – Markets: NSRS), a publicly traded company currently on the over-the-counter markets, announces that management’s plans are coming together. Our quest for a new symbol

The company has modified the company’s new direction to include topical and organic natural Cannabis and Hemp plant-based medical products as we have expressed. We have restructured the company with a productive reorganization the company and have started preparing to begin storing and manufacturing Cannabis Oil for our Clinical Trials with the FDA for our pain relief and Cancer Treatment products. The company is currently
manufacturing products for customers and/or patients for testing in the Clinical
Trials. Soon as we are issued our new symbol we will begin our first stage of
the trails. Phase one … Soon to be announced.

More on Spindigit:

MedCann Industries, Inc. is a cannabis and hemp-based manufacturing and cultivation company with 4 subsidiaries. MedCann has begun the new format for OTC Market Disclosure and Financial filings. We have voluntarily filed 8-K’s for the last two years and are presently up to date with all other filings.

MedCann Industries, Inc. Has changed to what we feel is a more professional Transfer Agent in Las Vegas and they will begin operations for us shortly.

The company is Pacific Stock Transfer.

“C.E.O. John Vivian stated: This has been the most roller coaster ride I have ever experienced. Navigating the various governmental agencies, trying to complete forms, answer questions for FINRA and post our Corporate Actions all the while dealing with the challenges FINRA, OTC Markets and all companies face in this pandemic times.”

Safe Harbor Provision
This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties and events
that may be beyond the control of MedCann Industries, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, the availability of technical personnel, changes in technology and competition.

Source: John Vivian; Transitioning CEO, 818-357-3185